Evidence map›Paper›PMID 30157378›Full record

ArticleAnalytical chemistry2018

Label-Free Prostate Cancer Detection by Characterization of Extracellular Vesicles Using Raman Spectroscopy.

Wooje Lee, Afroditi Nanou, Linda Rikkert, Frank A W Coumans, Cees Otto, Leon W M M Terstappen, Herman L Offerhaus

Abstract read
In one paragraph

Article in Analytical chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wooje LeeOptical Sciences, MESA+ Institute for Nanotechnology , University of Twente , 7500 AE , Enschede , The Netherlands.ORCID 0000-0002-6238-2898
Afroditi NanouDepartment of Medical Cell BioPhysics, MIRA Institute , University of Twente , 7500 AE , Enschede , The Netherlands.
Linda RikkertDepartment of Medical Cell BioPhysics, MIRA Institute , University of Twente , 7500 AE , Enschede , The Netherlands.
Frank A W CoumansVesicle Observation Centre, Academic Medical Center , University of Amsterdam , 1105 AZ , Amsterdam , The Netherlands.
Cees OttoDepartment of Medical Cell BioPhysics, MIRA Institute , University of Twente , 7500 AE , Enschede , The Netherlands.
Leon W M M TerstappenDepartment of Medical Cell BioPhysics, MIRA Institute , University of Twente , 7500 AE , Enschede , The Netherlands.
Herman L OfferhausOptical Sciences, MESA+ Institute for Nanotechnology , University of Twente , 7500 AE , Enschede , The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian cells release extracellular vesicles (EVs) into their microenvironment that travel the entire body along the stream of bodily fluids. EVs contain a wide range of biomolecules. The transported cargo varies depending on the EV origin. Knowledge of the origin and chemical composition of EVs can potentially be used as a biomarker to detect, stage, and monitor diseases. In this paper, we demonstrate the potential of EVs as a prostate cancer biomarker. A Raman optical tweezer was employed to obtain Raman signatures from four types of EV samples, which were red blood cell- and platelet-derived EVs of healthy donors and the prostate cancer cell lines- (PC3 and LNCaP) derived EVs. EVs' Raman spectra could be clearly separated/classified into distinct groups using principal component analysis (PCA) which permits the discrimination of the investigated EV subtypes. These findings may provide new methodology to detect and monitor early stage cancer.

Indexed as

Blood PlateletsErythrocytesExtracellular VesiclesHumansMaleProstatic NeoplasmsSpectrum Analysis, Raman

Identifiers

PMID30157378
PMCPMC6170952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.